| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |